ProFactor Pharma
Eugenia Wachters, MSc, MBA, is currently serving as the Chief Operating Officer at ProFactor Pharma Ltd, a biotech company developing a blood clotting factor replacement therapy for Haemophilia A. Previously, Eugenia held various leadership positions at companies such as Healx, Sanofi, Boehringer Ingelheim, and GSK. Eugenia has a background in biology and has also completed an Executive MBA program at Rotterdam School of Management, Erasmus University.
This person is not in any teams
ProFactor Pharma
ProFactor Pharma Limited (PFP) is a UK based company formed in 2009 by Professor J H McVey and Dr Ian Garner, who had been working with recombinant human Factor VIII (rhFVIII) for over 25 years, together with Co-founders Richard Cruse, Bruce Vernon and Hugh Ilyine, a team with many years of biotech experience.